| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |